EOLS- Evolus, Inc.

Name: Evolus, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Evolus, Inc. (EOLS) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EOLS is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Moatazedi David	604.7K	$3.85M	-
Other	Avelar Rui	427.4K	$2.72M	-
Dir	Malik Vikram	321.1K	$2.04M	-
CFO	Mitchell Tatjana	226.1K	$1.44M	-
CFO	Beaver Sandra	167.1K	$1.06M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 19, 2024	Avelar Rui66	See Remarks	Sell	27,603	$13.92	$384,349.69	-6.9%	-22.2%	-3.6%
Mar 19, 2024	Beaver Sandra66	Chief Financial Officer	Sell	5,672	$13.92	$78,978.06	-3.5%	-22.2%	-3.6%
Mar 19, 2024	Moatazedi David66	See Remarks	Sell	96,566	$13.92	$1,344,604.30	-12.2%	-22.2%	-3.6%
Feb 22, 2024	Moatazedi David66	See Remarks	Sell	7,706	$13.08	$100,803.73	-1.0%	-1.7%	+6.3%
Feb 22, 2024	Avelar Rui66	See Remarks	Sell	1,821	$13.08	$23,820.87	-0.5%	-1.7%	+6.3%
Feb 22, 2024	Beaver Sandra66	Chief Financial Officer	Sell	1,821	$13.08	$23,820.87	-1.1%	-1.7%	+6.3%
Jan 30, 2024	Parschauer Karah Herdman77	Director	Sell	11,931	$13.14	$156,732.77	-27.6%	-9.7%	+12.3%
Dec 8, 2023	Moatazedi David66	See Remarks	Sell	82,648	$9.95	$822,395.97	-6.3%	+51.2%	+29.4%
Oct 16, 2023	Medytox Inc.	Former 10% Owner	Sell	1,690,663	$7.50	$12,679,972.50	-33.3%	+25.7%	+101.2%
Sep 6, 2023	Beaver Sandra66	Chief Financial Officer	Sell	3,178	$9.70	$30,826.60	-2.7%	+1.7%	+53.5%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC